Showing results (91-100 of 176) with videos related to
Sort By:
Pageof 18
Journal of Clinical Medicine|February 25, 2022
Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the ArtEdoardo Vespa, Ferdinando D'Amico, Mauro Sollai, et al.Digestion|September 14, 2017
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life SettingMariangela Allocca, Rosario Landi, Stefanos Bonovas, et al.United European Gastroenterology Journal|March 2, 2022
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort studyMariangela Allocca, Cecilia Dell'Avalle, Vincenzo Craviotto, et al.Best Practice & Research. Clinical Gastroenterology|August 6, 2025
The role of diet in inflammatory bowel disease: A comprehensive review of the literatureIlaria Faggiani, Jacopo Fanizza, Sara Massironi, et al.Current Drug Targets|December 14, 2020
New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel DiseasesLaura Loy, Gionata Fiorino, Giulia Roda, et al.United European Gastroenterology Journal|February 19, 2025
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatmentFerdinando D'Amico, Sarah Bencardino, André Gonçalves, et al.Expert Review of Gastroenterology & Hepatology|August 8, 2020
Endoscopy after surgery in inflammatory bowel disease: Crohn's disease recurrence and pouch surveillanceEdoardo Vespa, Federica Furfaro, Mariangela Allocca, et al.Expert Opinion on Pharmacotherapy|April 11, 2023
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitorsAlexander Goetsch, Ferdinando D'Amico, Mariangela Allocca, et al.Immunotherapy|April 17, 2024
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's diseaseFrancesca Lusetti, Ferdinando D'Amico, Mariangela Allocca, et al.Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine ApproachesLucia Centanni, Clelia Cicerone, Fabrizio Fanizzi, et al.Pageof 18